JPRN-UMIN000016856已完成未知
Evaluation of the clinical efficacy of flutiform®(fluticasone propionate /formoterol fumarate) on severe persistent bronchial asthma - Evaluation of the clinical efficacy of flutiform®(fluticasone propionate /formoterol fumarate) on severe persistent bronchial asthma
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Patients with COPD (2)Patients who take SABA other than treatment of exacerbations (3)Patients who had a history of adverse reaction to ICS or LABA (4)Patients who took flutiform ® within four weeks (5)Patients with severe cardiac, hepatic, renal, pulmonary, or hematologic disease (6)Current malignancy (7)Smoking within past 1 year (8)Those who are pregnant, under-lactation, or desire pregnancy (9)Unsuitability as determined by the investigator
研究者
相似试验
已完成
2 期
Flutiform® Compared With Seretide® in the Treatment of COPDChronic Obstructive Pulmonary DiseaseNCT02195375Mundipharma Research Limited923
已完成
3 期
Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible AsthmaAsthmaNCT01099722Mundipharma Research Limited261
进行中（未招募）
3 期
Evaluation of the efficiency of photobiomodulation in the prevention of oral mucositis? in chemotherapy-treated cancer patientsPrevention of oral mucositis? in chemotherapy-treated cancer patientsOral HealthISRCTN70634383Damascus University45
进行中（未招募）
不适用
Clinical study on the efficacy of flutamide for androgen dependent dilated cardiomyopathyDilated cardiomyopathyJPRN-jRCTs051180123Onoue Kenji2
进行中（未招募）
不适用
12 week Chronic Obstructive Pulmonary Disease (COPD)studysubjects with Chronic Obstructive Pulmonary Disease (COPD)MedDRA version: 14.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-024435-16-DEGlaxoSmithKline Research & Development Ltd248